These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 703529)

  • 1. Pyrroles in neuropsychiatric and porphyric disorders: confirmation of a metabolite structure by synthesis.
    Irvine DG
    Life Sci; 1978 Sep; 23(9):983-90. PubMed ID: 703529
    [No Abstract]   [Full Text] [Related]  

  • 2. Kryptopyrrole and other monopyrroles in molecular neurobiology.
    Irvine DG
    Int Rev Neurobiol; 1974; 16(0):145-82. PubMed ID: 4606712
    [No Abstract]   [Full Text] [Related]  

  • 3. Porphyrins and porphyrias: new horizons.
    Chatterji AK; Chatterjea JB
    Bull Calcutta Sch Trop Med; 1969 Jul; 17(3):87-91. PubMed ID: 5401900
    [No Abstract]   [Full Text] [Related]  

  • 4. Tryptophan metabolism in porphyria, schizophrenia, and a variety of neurologic and psychiatric diseases.
    PRICE JM; BROWN RR; PETERS HA
    Neurology; 1959 Jul; 9(7):456-68. PubMed ID: 13666928
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological and biochemical properties of kryptopyrrole and its oxidation products possibly related to acute intermittent porphyria.
    Wetterberg L; Formgren B
    Ann Clin Res; 1976; 8 Suppl 17():162-7. PubMed ID: 1008487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of magnetic resonance spectroscopy to the investigation of neuropsychiatric disorders.
    Dager SR; Steen RG
    Neuropsychopharmacology; 1992 Jun; 6(4):249-66. PubMed ID: 1632893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heavy metals and neuropsychiatric disorders in six-year-old children. Aspects of dental lead and cadmium.
    Gillberg C; Norén JG; Wahlström J; Rasmussen P
    Acta Paedopsychiatr; 1982 Oct; 48(5):253-63. PubMed ID: 6184942
    [No Abstract]   [Full Text] [Related]  

  • 8. Porphyria and porphyrin metabolism.
    Straka JG; Rank JM; Bloomer JR
    Annu Rev Med; 1990; 41():457-69. PubMed ID: 2184744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychiatric disorders and the multiple human brain serotonin receptor subtypes and subsystems.
    Murphy DL
    Neuropsychopharmacology; 1990; 3(5-6):457-71. PubMed ID: 2078279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical basis and regulatory mechanisms of porphyrin synthesis.
    Neuberger A
    Proc R Soc Med; 1968 Feb; 61(2):191-3. PubMed ID: 5637834
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies of the molecular pathogenesis of hexane neuropathy. II. Evidence that pyrrole derivatization of lysyl residues leads to protein crosslinking.
    Graham DG; Anthony DC; Boekelheide K; Maschmann NA; Richards RG; Wolfram JW; Shaw BR
    Toxicol Appl Pharmacol; 1982 Jul; 64(3):415-22. PubMed ID: 6814014
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on free aminoacids and sugars in cerebrospinal fluid and serum in neuro-psychiatric disorders by circular chromatographic technique.
    Rao BS
    Neurol India; 1970 Mar; 18(1):13-6. PubMed ID: 5439379
    [No Abstract]   [Full Text] [Related]  

  • 13. Porphyrin synthesis in drug induced hepatic porphyria.
    Rao MR; Padmanaban G; Sarma PS
    Biochem Pharmacol; 1971 Aug; 20(8):2001-7. PubMed ID: 5137957
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroinflammation in psychiatric disorders: An introductory primer.
    Dunn GA; Loftis JM; Sullivan EL
    Pharmacol Biochem Behav; 2020 Sep; 196():172981. PubMed ID: 32621927
    [No Abstract]   [Full Text] [Related]  

  • 15. [Correlation between neurochemistry and psycho-neurologic diseases].
    Tsukada Y
    Nihon Rinsho; 1976 Sep; 34(9):2695-9. PubMed ID: 1033307
    [No Abstract]   [Full Text] [Related]  

  • 16. [Regulatory disturbances in acute intermittent porphyria and lead poisoning].
    Goreczky L; Róth I
    Z Klin Chem Klin Biochem; 1969 Jul; 7(4):333-8. PubMed ID: 5357651
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuropeptides--clinicobiological implications in neurology and psychiatry.
    Lugoji G
    Neurol Psychiatr (Bucur); 1987; 25(1):3-14. PubMed ID: 3551032
    [No Abstract]   [Full Text] [Related]  

  • 18. Intermittent acute porphyria--demonstration of a genetic defect in porphobilinogen metabolism.
    Meyer UA; Strand LJ; Doss M; Rees AC; Marver HS
    N Engl J Med; 1972 Jun; 286(24):1277-82. PubMed ID: 5024458
    [No Abstract]   [Full Text] [Related]  

  • 19. The serum porphobilinogen and hepatic porphobilinogen deaminase in normal and porphyric individuals.
    Miyagi K; Cardinal R; Bossenmaier I; Watson CJ
    J Lab Clin Med; 1971 Nov; 78(5):683-95. PubMed ID: 5128821
    [No Abstract]   [Full Text] [Related]  

  • 20. Cannabinoid receptors and their relationships with neuropsychiatric disorders.
    Gambi F; De Berardis D; Sepede G; Quartesan R; Calcagni E; Salerno RM; Conti CM; Ferro FM
    Int J Immunopathol Pharmacol; 2005; 18(1):15-9. PubMed ID: 15698507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.